Technology
Health
Pharmaceutical

Gamida Cel

$4.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-4.42%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Gamida Cel and other stocks, options, ETFs, and crypto commission-free!

About GMDA

Gamida Cell Ltd. Ordinary Shares, also called Gamida Cel, is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure blood cancer and rare serious hematologic diseases. Read More The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Employees
73
Headquarters
Jerusalem, Jerusalem
Founded
1998
Market Cap
108.61M
Price-Earnings Ratio
Dividend Yield
Average Volume
21.49K
High Today
$4.54
Low Today
$4.32
Open Price
$4.52
Volume
4.55K
52 Week High
$15.41
52 Week Low
$4.32

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Cancer Prevention
2018 IPO
Asia (Non-China)

GMDA Earnings

-$32.79
-$21.98
-$11.18
-$0.37
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.